CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Negative Risk Markers for Cardiovascular Events in the Elderly Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial. Intravascular ultrasound guidance improves clinical outcomes during implantation of both first- and second-generation drug-eluting stents: a meta-analysis 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Discrepancies in Measurement of the Thoracic Aorta: JACC Review Topic of the Week Prognostic implications of baseline 6‐min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure Chimney technique in a TAVR-in-TAVR procedure with high risk of left main artery ostium occlusion Colchicine Reduces Cardiovascular Events in Chronic Coronary Disease
|<<... 100 101 102 103 104 105 106 ...>>|

Clinical Trial2012 Apr 24;125(16):2015-26.

JOURNAL：Circulation. Article Link

Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial

Valgimigli M, Campo G, Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study (PRODIGY) Investigators. Keywords: DAPT duration; coronary artery disease; percutaneous coronary intervention; platelet aggregation; inhibitors; stents; thrombosis

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top